ReviewDrug design, development and therapy2016

Spotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis C.

Duminda Suraweera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.